Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.04), $0.04 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $150.2 million versus the consensus estimate of $143.02 million.

GUIDANCE:

Evolent Health sees Q4 2018 revenue of $167-171 million, versus the consensus of $152.22 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.